7 Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus

Acbay, 1996, Can metformin reduce insulin resistance in polycystic ovary syndrome?, Fertility and Sterility, 65, 946 Bergstrom, 1990, Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance, Journal of Clinical Endocrinology and Metabolism, 71, 1447, 10.1210/jcem-71-6-1447 Burghen, 1980, Correlation of hyperandrogenism with hyperinsulinaemia in polycystic ovarian disease, Journal of Clinical Endocrinology and Metabolism, 50, 113, 10.1210/jcem-50-1-113 Cahill, 1988, Beta-cell deficiency, insulin resistance, or both?, New England Journal of Medicine, 318, 1268, 10.1056/NEJM198805123181909 Cerasi, 1967, The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus, Acta Endocrinology, 55, 278, 10.1530/acta.0.0550278 Chang, 1983, Steroid secretion in polycystic ovary disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist, Journal of Clinical Endocrinology and Metabolism, 56, 897, 10.1210/jcem-56-5-897 Crave, 1995, Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women, Journal of Clinical Endocrinology and Metabolism, 80, 2057, 10.1210/jc.80.7.2057 Dahlgren, 1992, Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones, Fertility and Sterility, 57, 505, 10.1016/S0015-0282(16)54892-4 DeFronzo, 1992, Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview, Diabetologia, 35, 389, 10.1007/BF00401208 Duleba, 1993, Insulin actions on ovarian steroidogenesis are not modulated by metformin, Human Reproduction, 8, 1194, 10.1093/oxfordjournals.humrep.a138227 Dunaif, 1992, Insulin resistance and ovarian hyperandrogenism, Endocrinologist, 2, 248, 10.1097/00019616-199207000-00007 Dunaif, 1992, Diabetes mellitus and polycystic ovary syndrome Dunaif, 1993, Insulin resistance in polycystic ovarian syndrome, Annals of the New York Academy of Science, 687, 60, 10.1111/j.1749-6632.1993.tb43854.x Dunaif, 1996, β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 81, 942, 10.1210/jc.81.3.942 Dunaif, 1988, The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 66, 131, 10.1210/jcem-66-1-131 Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diabetes.38.9.1165 Dunaif, 1987, Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia, Journal of Clinical Endocrinology and Metabolism, 65, 499, 10.1210/jcem-65-3-499 Dunaif, 1996, The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 81, 3299, 10.1210/jc.81.9.3299 Efendic, 1984, Aspects of the pathogenesis of type 2 diabetes, Endocrinology Reviews, 5, 395, 10.1210/edrv-5-3-395 Ehrmann, 1995, Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism, Endocrine Reviews, 16, 322, 10.1210/er.16.3.322 Ehrmann, 1996, A longitudinal study of glucose tolerance in women with polycystic ovary syndrome Ehrmann, 1992, Detection of functional ovarian hyperandrogenism in women with androgen excess, New England Journal of Medicine, 327, 157, 10.1056/NEJM199207163270304 Ehrmann, 1995, Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus, Journal of Clinical Investigation, 96, 520, 10.1172/JCI118064 Ehrmann, 1997, Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 82, 524, 10.1210/jc.82.2.524 Ehrmann, 1997, Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism Falcone, 1992, Impaired glucose effectiveness in patients with polycystic ovary syndrome, Human Reproduction, 7, 922, 10.1093/oxfordjournals.humrep.a137771 Fendri, 1993, Metformin effects on peripheral sensitivity to insulin in non diabetic obsese subjects, Diabetes and Metabolism, 19, 245 Garvey, 1988, Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM: correlation with urinary C-peptide excretion, Diabetes, 37, 590, 10.2337/diabetes.37.5.590 Hansen, 1982, Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans, Journal of Clinical Endocrinology and Metabolism, 54, 785, 10.1210/jcem-54-4-785 Harris, 1987, Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in a US population aged 20–74 yr, Diabetes, 36, 523, 10.2337/diabetes.36.4.523 Holte, 1994, Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance, Journal of Clinical Endocrinology and Metabolism, 78, 1052, 10.1210/jc.78.5.1052 Jialal, 1987, Evidence for insulin resistance in nonobese patients with polycystic ovarian disease, Journal of Clinical Endocrinology and Metabolism, 64, 1066, 10.1210/jcem-64-5-1066 Johnston, 1990, Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients, Diabetic Medicine, 7, 119, 10.1111/j.1464-5491.1990.tb01345.x Kahn, 1993, Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function, Diabetes, 42, 1663, 10.2337/diabetes.42.11.1663 Kiddy, 1992, Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome, Clinical Endocrinology, 36, 105, 10.1111/j.1365-2265.1992.tb02909.x King, 1993, Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults, Diabetes Care, 16, 157, 10.2337/diacare.16.1.157 Kosaka, 1980, Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment, Diabetalogia, 18, 23, 10.1007/BF01228297 Lang, 1979, Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings, New England Journal of Medicine, 301, 1023, 10.1056/NEJM197911083011903 Lang, 1981, Brief, irregular of oscillations of basal plasma insulin and glucose concentrations in diabetic men, Diabetes, 30, 435, 10.2337/diabetes.30.5.435 Lang, 1982, Pulsatile, synchronous basal insulin and glucagon secretion in man, Diabetes, 31, 22, 10.2337/diabetes.31.1.22 Lillioja, 1993, Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians, New England Journal of Medicine, 329, 1988, 10.1056/NEJM199312303292703 McCance, 1997, Diagnosing diabetes mellitus—do we need new criteria?, Diabetologia, 40, 247, 10.1007/s001250050671 Marks, 1996, Metformin does not improve insulin sensitivity in insulin-resistant normoglycemic women with hirsutism Martin, 1992, Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study, Lancet, 340, 925, 10.1016/0140-6736(92)92814-V Matthews, 1983, Control of pulsatile insulin secretion in man, Diabetologia, 24, 231, 10.1007/BF00282705 Moller, 1991, Insulin resistance—mechanisms, syndromes, and implications, New England Journal of Medicine, 325, 938, 10.1056/NEJM199109263251307 Nestler, 1996, Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome, New England Journal of Medicine, 335, 617, 10.1056/NEJM199608293350902 Nestler, 1989, Suppression of serum insulin levels by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 68, 1027, 10.1210/jcem-68-6-1027 O'Meara, 1993, Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 92, 262, 10.1172/JCI116560 O'Meara, 1993, Defects in beta cell function in functional ovarian hyperandrogenism, Journal of Clinical Endocrinology and Metabolism, 76, 1241, 10.1210/jc.76.5.1241 O'Rahilly, 1986, β-cell dysfunction rather than insulin insensitivity is the primary defect in familial type 2 diabetes, Lancet, ii, 360, 10.1016/S0140-6736(86)90052-8 O'Rahilly, 1988, Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes, New England Journal of Medicine, 318, 1225, 10.1056/NEJM198805123181902 Perley, 1967, Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects, Journal of Clinical Investigation, 46, 1954, 10.1172/JCI105685 Polonsky, 1988, Abnormal patterns of insulin secretion in non-insulin dependent diabetes, New England Journal of Medicine, 318, 1231, 10.1056/NEJM198805123181903 Polonsky, 1988, Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects, Journal of Clinical Investigation, 81, 442, 10.1172/JCI113339 Rosenfield, 1990, Dysregulation of cytochrome P450c17 as the cause of polycystic ovary syndrome, Fertility and Sterility, 53, 785, 10.1016/S0015-0282(16)53510-9 Schumacher, 1992, Major gene effect for insulin levels in familial NIDDM pedigrees, Diabetes, 41, 416, 10.2337/diabetes.41.4.416 Seltzer, 1967, Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus, Journal of Clinical Investigation, 46, 323, 10.1172/JCI105534 Shapiro, 1988, Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose, Journal of Clinical Endocrinology and Metabolism, 67, 307, 10.1210/jcem-67-2-307 Simon, 1987, Ultradian oscillations of plasma glucose, insulin and C-peptide in man during continuous enteral nutrition, Journal of Clinical Endocrinology and Metabolism, 64, 669, 10.1210/jcem-64-4-669 Sturis, 1991, Entrainment of pulsatile insulin secretion by oscillatory glucose infusion, Journal of Clinical Investigation, 87, 435, 10.1172/JCI115015 Sturis, 1992, Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients, Diabetologia, 35, 681, 10.1007/BF00400263 Vague, 1982, The defective glucose-sensitivity of the B-cell in non-insulin dependent diabetes: improvement after twenty hours of normoglycemia, Metabolism, 31, 139, 10.1016/0026-0495(82)90125-1 Velazquez, 1994, Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy, Metabolism, 43, 647, 10.1016/0026-0495(94)90209-7 Warram, 1990, Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents, Annals of Internal Medicine, 113, 909, 10.7326/0003-4819-113-12-909